Last Price Today's Change   Day's Range   Trading Volume
2.88   -0.15 (4.95%)  2.82 - 3.02  6,728,600
Analyze this stock with MQ Trader system


Market Cap: 2,033 Million
NOSH: 706 Million
Avg Volume (4 weeks):3,426,190
4 Weeks Range:2.82 - 3.64
4 Weeks Price Volatility (%):
52 Weeks Range:1.05 - 4.38
52 Weeks Price Volatility (%):
Average Price Target: 1.88
Price Target Upside/Downside: -1.00
Stamp duty exempted for year 2021

Financial Highlight

Latest Quarter | Ann. Date 31-Dec-2020 [#4]  |  22-Feb-2021
Next QR | Est. Ann. Date: 31-Mar-2021  |  18-May-2021
T4Q P/E | EY: 34.69  |  2.88%
T4Q DY | Payout %: 2.25%  |  78.12%
T4Q NAPS | P/NAPS: 0.91  |  3.16
T4Q NP Margin | ROE: 10.28%  |  9.12%


Date Subject
23-Feb-2021 Mplus Market Pulse - 23 Feb 2021
28-Jan-2021 [转贴] [Video:浅谈DUOPHARMA BIOTECH BHD, DPHARMA, 7148] - James的股票投资James Share Investing
27-Jan-2021 PublicInvest Research Headlines - 27 Jan 2021
18-Jan-2021 [转贴] 医疗物流领域摩拳擦掌 疫苗概念股走俏
15-Jan-2021 Trading Stocks - Duopharma Biotech
14-Jan-2021 Duopharma next after Pharmaniaga to handle Covid-19 vaccination?
05-Jan-2021 Daily technical highlights – (DPHARMA, DKSH)
13-Nov-2020 Mplus Market Pulse - 13 Nov 2020
05-Nov-2020 热门股:联合药业 上挑RM4.23
05-Oct-2020 Trading Stocks - Duopharma Biotech
02-Oct-2020 热门股:联合药业 上挑RM3.80
19-Sep-2020 联合药业上挑RM3.47/敏源
15-Sep-2020 Daily Market Update - 15 Sept 2020 (DPHARMA, PLABS)
13-Sep-2020 [转贴] [Video:浅谈DUOPHARMA BIOTECH BHD, DPHARMA, 7148] - James的股票投资James Share Investing
01-Sep-2020 放眼5年内迈10亿大关‧联合药业跨向区域
29-Aug-2020 联合药业挑战RM3.89/敏源
25-Aug-2020 热门股:联合药业 上挑RM3.76
17-Aug-2020 PublicInvest Research Headlines - 17 Aug 2020

Business Background

Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia. The company provides products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, hemodialysis solutions, sterile irrigation solutions, sterile powder and small volume injectable forms, dental cartridges, and eye drop preparations. It offers generic and halal pharmaceutical products; and over-the-counter products primarily under the Champs, Flavettes, Proviton, Naturalle, Uphamol, Eye Glo, Donna, and Alucid brands, as well as analgesics, antihistamines, etc. The company also operates under the OMESEC brand name. In addition, it is also involved in the property management activities; and distribution of chemical products. Duopharma Biotech Berhad also exports its products to Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, the Republic of Yemen, Singapore, and Hong Kong. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1979 and is based in Klang, Malaysia. Duopharma Biotech Berhad is a subsidiary of Permodalan Nasional Berhad.
Trade this stock for as low as 0.05% brokerage. Find out more.

  11 people like this.
emc2garylow Gloves guy those earn money one already go tech stock, only those stuck at high price one still holding, no way can cut lose and dun want to cut lose... Maybe keep for next pandemic hahah
24/02/2021 7:26 PM
ikenduit institution leaving market bcos of stamp duty / capital tax gain rumors in HK. now left us retailers to support
24/02/2021 8:13 PM
Chua Joe Beng sad day for gloves n pharmaceuticals stocks!
24/02/2021 8:16 PM
emc2garylow Hk news also can link to here, very pro lor you
24/02/2021 8:18 PM
sharewiz118 PM already inoculate with vaccine why stock price dropping ??? Why
24/02/2021 9:36 PM
Mohd Yazid Mohd Ali TP 1.88 ONLY?
24/02/2021 10:05 PM
pantor oversold. tomorrow up
24/02/2021 10:24 PM
AbsoluteNoob pungut pungut
25/02/2021 9:45 AM
eYuppie Still going down, pening kepala.
25/02/2021 9:53 AM
Happy_Sad good result also down. WTH
25/02/2021 10:41 AM
pharker vaccine play is now on the start of a down trend..just like glove before..

f you don't get out now..then you will be trapped at high price. just like those glove trapped at high price.

better move on
25/02/2021 12:06 PM
pharker In Bursa, when good news is out, thats when people start selling and down trend begins
25/02/2021 12:09 PM
williamtkb Pharma 3days dropped Rm1. Today got buying queue already. The buying up might fast too.
25/02/2021 12:29 PM
ikenduit Anyway to check if its RSS shorting play the past few days?
25/02/2021 12:53 PM
Mohd Yazid Mohd Ali TP 1.88 ONLY ,NEXT TP .50 CENTS
25/02/2021 1:41 PM
pharker first glove up, follow by vaccine up, then recovery up , then tech up, then O&G up....

Now glove down already, next to follow down..you know what lo..
25/02/2021 1:57 PM
cm2727 @ikenduit, dpharma shorted 35,000 shares, pharmaniaga 0..so not sure who pressing it..
25/02/2021 2:14 PM
ikenduit cm2727. tks for the info. possibly sharks like what emc2garylow mentoned
25/02/2021 3:02 PM
emc2garylow Dun compare gloves to vaccine counter although they are both in health care.... Gloves is expected to down because pandemic going to end by vaccine, while vaccine is new emerging market, next few year u still need to inoculate one, is not one time business ok..... Shark has been playing with alot counter to press down the price, look at yesterday D&O price from 3.6 press down to 3.3 then after market close result out shoot up to 4....and FPI one week time from 3.4 press down to 2.5 yesterday, today back to 3, QR will out by today or tomorrow... Look at how shark playing, if u can't hold it, u will just flush out..
25/02/2021 3:14 PM
ikenduit emc2garylow. tks for the advise. am holding tight. in this scenario is it good time to avg down bit by bit?
25/02/2021 3:22 PM
POONJ Tomorrow maybe will rebound back.
25/02/2021 7:39 PM
livestockpicks I want see QR bad, how low the share price will go
25/02/2021 8:18 PM
Godofgambler Tomorrow fly confirm
25/02/2021 9:31 PM
emc2garylow Look at scib share price, from rm 3 drop until rm 1.7 yesterday, 50% drop, how many retailers are flush out? But today QR out revenue and profit break fantastic record, tomorrow scib will fly like D&O...all those fantastic counter went through this flushing... Shark is manipulating to flush u out...
25/02/2021 10:24 PM
Klse0314 livestockpicks, God will hear what you said.. good luck to you.
26/02/2021 11:23 AM
scottsytong Pfizer (NYSE:PFE) CEO Albert Bourla said in an interview with NBC News' Lester Holt that because additional variants of COVID-19 are likely to crop up, individuals may need a COVID-19 vaccine annually.

"Every year, you need to go to get your flu vaccine," Bourla said. "It's going to be the same with COVID. In a year, you will have to go and get your annual shot for COVID to be protected."

Pfizer and other drugmakers involved in COVID-19 vaccines are working on vaccine boosters that will improve protection against variants, such as those first discovered in the United Kingdom, South Africa, and Brazil.

Bourla told NBC News that a third COVID-19 vaccine dose "will boost the antibody response 10- to 20-fold."

Pfizer and its partner BioNTech SE (NASDAQ:BNTX) earlier today announced they have started a study evaluating a third dose of their COVID-19 vaccine to determine how it might further boost immunity and its effectiveness against the variants.

In January, the executives from Moderna (NASDAQ:MRNA) voiced similar remarks. "From what we’ve seen so far, I think our expectation is that the vaccination should last you at least a year," Moderna’s outgoing chief medical officer, Dr. Tal Zaks had said at the JPMorgan Healthcare Conference.

"I think this will become a market like flu," Moderna CEO Stephane Bancel told CNBC in January predicting that the emergence of new variants will require adjustments to vaccines.

Yesterday, Moderna announced that it completed the manufacturing of clinical trial material for a variant-specific vaccine candidate targeting the SARS-CoV-2 variant first identified in South Africa.
26/02/2021 12:09 PM
aliffazmi KUALA LUMPUR: Duopharma Biotech Bhd has confirmed it will procure and supply to the Health Ministry the Covid-19 vaccine known as Sputnik V developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.

In a statement today, Duopharma said its wholly-owned Duopharma (M) Sdn Bhd (DMSB) had signed a term sheet agreement with the Russian Direct Investment Fund (RDIF) to secure 6.4 million doses of Sputnik V.

RDIF is the appointed marketing agent for Gamaleya for all international markets.

RDIF has established partnerships in India, China and South Korea to manufacture the Sputnik V vaccine in order to cope with the global growing demand for this vaccine.

Duopharma said supplies of the Sputnik V vaccine could be from any of RDIF's partners, subject to approval by Malaysia's National Pharmaceutical Regulatory Agency (NPRA).

Duopharma group managing director Leonard Ariff Abdul Shatar said its latest initiative fully supports the Covid-19 National Vaccination Plan.

"Our investment in vaccine fill and finish facilities and cold chain distribution synchronously aligns both with the government's recently announced aim to develop in-country vaccines in the long term to reduce dependency on other countries," he said.

Besides that, Duopharma said together with RDIF and Gamaleya Institute, was exploring further collaboration to enhance its capabilities in research and development, technology transfer, local manufacturing, and supply of the vaccine to other Asean countries.

Subsequently, DMSB has also entered into a term sheet agreement with the MOH to supply 6.4 million doses to vaccinate 3.2 million Malaysians.

ThecSputnik V vaccine will be supplied in phases this year.

DMSB will also provide warehousing, logistics, ground support and other services to the government hospitals and clinics.

Leonard said the company had put in place an existing inert human vaccine fill and finish line at its plant in Klang, and it was ready to be used.

"We are also positioning ourselves to upgrade our facility to ensure the equipment will accommodate the localisation of vaccine manufacturing in Malaysia, which consequently can increase vaccine accessibility, reduce dependency on importation, and ensure long-term self-sufficiency of vaccines for the country.

"This is in line with our mission to become a leading healthcare group providing quality and innovative solutions," he said.
26/02/2021 1:46 PM
Godofgambler “Our vaccine roadmap, including the F&F facility and a full manufacturing plant will not only be the first in Malaysia, it will also be the first halal vaccine plant in the world. Many renowned vaccine manufacturers will be involved in the know-how and technology transfer in which Sinovac will participate for two vaccines, InsyaAllah,” said Zulkarnain.

In the long term, he said, besides helping the nation to reduce dependency on imported vaccines, Pharmaniaga’s foray into vaccine venture will help the government to reduce its yearly vaccine expenditure.
27/02/2021 12:17 PM
thor85 emc2garylow Gloves will continue making fantastic profit for the next few years. As an essential item in hospital gloves have experience acute shortage due to covid.
27/02/2021 12:32 PM
thor85 For duopharma it will making a better profit from the vaccine. Govt payment to duopharma should be very good as usual.
27/02/2021 12:36 PM
willc48 china cina punya vaksin tolong geng umno lagi. untung betuk duduk saja tapi tengok beberapa akan tercemar since tidak di botol di China
01/03/2021 9:31 AM
eYuppie Sad with DPharma. Still falling. Why??!
01/03/2021 12:26 PM
New2020 When the Russia vaccine will arrive Mal???
01/03/2021 1:27 PM
ikenduit haha. bottling in M'sia oso want to politicize. do some homework before u talk nonsense liao.
01/03/2021 1:59 PM
eYuppie We are played out by the Smart Money! Only I think if we have the holding power, then we can compete with them, am I right?
01/03/2021 3:58 PM
eYuppie What happened? Pharma Up but DPharma Down??!
01/03/2021 4:16 PM
Canlah @eYuppie chill. how many you hold? many ar?
01/03/2021 5:25 PM
MisterN https://www.astroawani.com/berita-malaysia/covid19-saya-tidak-akan-ambil-suntikan-vaksin-pfizerbiontech-khairy-285043
01/03/2021 8:54 PM
yongyong88 waterfall...
02/03/2021 9:46 AM
Mohd Yazid Mohd Ali Overvalued tp 1.88 only
02/03/2021 10:01 AM
jupiter wht happen
02/03/2021 10:10 AM
Josh72 pelik bin ajaib. vaccines already rolled out but this stock going south.
02/03/2021 11:03 AM
eYuppie Yup, amat pelik. Smart money dah pandai manipulasi sampai paksa kita ni rugi. Bila ada yang rugi, siapa yang untung?
02/03/2021 11:24 AM
eYuppie Those sifu said, follow the Smart Money to play but how do we follow, we cannot read what they are up to. Nowadays, charts seem becoming less realiable, volume does not mean much, just my own observations.
02/03/2021 11:27 AM
MelonCheng i thought DPHARMA QR result is good and vaccine is coming soon. why drop like shit?
02/03/2021 11:45 AM
cm2727 Because its Bursa.. Good results drop, Bad results drop more, good news drop, no news shoot up, bad qr up, Mou shoot up, Sign agreement d gap down.

welcome to bursa...i am speechless as well
02/03/2021 12:14 PM
Daniel Wong I think they want to press the going expire warrants until out of money
02/03/2021 1:16 PM
Newbie789 When is the expire warrant?
02/03/2021 4:26 PM
greencode The vaccine already bottled so no function of Dpharma in this vaccine distribution.
02/03/2021 6:17 PM
greencode Most of the vaccine is ready made
02/03/2021 6:18 PM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate

424  681  523 

Top 10 Active Counters
 KOMARK-WC 0.12+0.02 
 GFM-WC 0.125-0.075 
 AIMFLEX 0.315+0.06 
 STRAITS-WA 0.12-0.015 
 STRAITS 0.21+0.01 
 GFM 0.28-0.125 
 GRANFLO 0.58+0.235 
 LAYHONG-WA 0.075+0.02 
 AAX 0.09-0.005 
 AT 0.115-0.01 


1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!